戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              TPN administration in wild-type mice resulted in several
2                                              TPN also up-regulated phosphorylated (p)-beta-catenin (S
3                                              TPN causes depression of mucosal immunity compared with
4                                              TPN causes global intestinal barrier failure, but elemen
5                                              TPN causes peptides to associate and dissociate faster o
6                                              TPN duration ranged from 2 to 252 months.
7                                              TPN significantly changed the amount of T1Rs, GLM recept
8                                              TPN significantly down-regulated E-cadherin and beta-cat
9                                              TPN use, if correctly indicated, is a clinical sign of i
10                                              TPN was initiated in 40 adult patients and continued for
11                                              TPN(Q) inhibits the ROMK1 and GIRK1/4 inward-rectifier K
12                                              TPN-Y1/K12/Q13 and mono-iodo-TPN-Y1/K12/Q13 ([(127)I]TPN
13                                              TPNs receive input from gustatory receptor neurons and r
14 is not related to serum Ab, because 10 of 13 TPN-fed mice shed virus into their nasal secretions desp
15 er of hemodialysis days [6.20; (2.67-14.4)], TPN duration [2.87; (1.40-5.90)], and mean number of red
16 er of hemodialysis days [3.84; (1.75-8.40)], TPN duration [11.0; (5.52-21.7)] and mean number of red
17 acing their variable region with that from a TPN-sensitive channel.
18                     Our data indicate that a TPN-assisted mechanism of peptide selection relies on di
19  IEL changes in phenotype and function after TPN administration.
20 ncreased risk of mortality even >1.5 y after TPN use.
21  mutagenesis studies on both the channel and TPN(Q) together strongly suggest that to block the K(+)
22  discharge, post-operative complication, and TPN requirement.
23 +/- 0.18 attomoles/microL in the control and TPN groups, respectively.
24  10 received daily GH, systemic insulin, and TPN.
25 idino Yellow into TPNs revealed that RPM and TPN motoneurons are indeed interdigitated in T17-S1.
26 ed a complete concordance with CRT, TAP, and TPN but not with calnexin.
27 at the physical interaction between TAP2 and TPN is disrupted by benzene, a compound known to interfe
28                  Ileal bacteria from TEN and TPN piglets were also examined for their ability to grow
29  was equally complex in the ileum of TEN and TPN piglets, but profiles clustered according to mode of
30 DNA were observed between the treatments and TPN alone (SEN: 15-59% increase; GLP-2: 14-84% increase;
31 re identical, as was the use of antibiotics, TPN, and enteral feedings.
32               Although both N-domains act as TPN-docking sites, various studies suggest a functional
33 nt deprivation, to study this interaction as TPN results in mucosal atrophy due to decreased IEC prol
34 ble TNF-alpha signaling from IECs attenuates TPN-induced mucosal atrophy.
35 on, not the composition of the diet, because TPN solution fed orally via gastrostomy instead of i.v.
36 interaction or the complex formation between TPN and MHC I.
37        We found that the interaction between TPN(Q) and the ROMK1 channel is a bimolecular reaction,
38  of 120% to 130% of calories is delivered by TPN.
39 d, jugular and portal catheters, were fed by TPN for 7 days.
40 is essential for high-affinity inhibition by TPN and that variability in the region underlies the gre
41 t processes may occur in humans nourished by TPN and may thereby contribute to intestinal dysfunction
42 el transplants and tissue growth from cells, TPN will be a temporary measure rather than a lifetime r
43  in association with TAP and two chaperones, TPN and CRT.
44 determined long-term survival after clinical TPN use in a consecutive cohort who were attending an ac
45      Evening infusions of calcium-containing TPN eliminated the nocturnal rise in serum PTH, increase
46    In the present study, the TPN derivative, TPN-Y1/K12/Q13, has been synthesized and radiolabeled to
47 ity but retain high affinity, we derivatized TPN(Q) by replacing histidine 12 with lysine.
48                                Two different TPN feeding strategies were compared: hypocaloric feedin
49 hat are unable to conformationally disengage TPN from class I molecules are excluded from the reperto
50 on dysfunction in ADHD emphasize altered DMN-TPN interactions.
51 a priori hypothesis, we observed reduced DMN-TPN segregation co-occurring with structural abnormaliti
52 ating glucagon-like peptide 2 (GLP-2) during TPN.
53 but not GH, prevented mucosal atrophy during TPN, although GH elevated plasma IGF-I and increased bod
54  factorial design and maintained with either TPN or PN for 7 d.
55  GIRK1 subunit confers the high affinity for TPN.
56 crosis factor-alpha is a critical factor for TPN-associated epithelial barrier dysfunction, and both
57         Treatment for 10 d with calcium-free TPN restored the nocturnal rise in serum PTH and increas
58  follow-up, including 8 who were weaned from TPN after intestinal transplantation.
59                              IL-7 mice given TPN, however, maintained IEL proliferation, and sustaine
60 oxidized by air, which significantly hinders TPN binding to the channels.
61 sed clinically to sustain patients; however, TPN is associated with profound mucosal atrophy, which m
62 rogen balance in comparison with hypocaloric TPN.
63                                      [(125)I]TPN-Y1/K12/Q13 binds in a saturable, time-dependent, and
64 aken together, they demonstrate that [(125)I]TPN-Y1/K12/Q13 represents the first high specific activi
65 12/Q13 and mono-iodo-TPN-Y1/K12/Q13 ([(127)I]TPN-Y1/K12/Q13) inhibit with high affinity rat but not h
66 ls decreased significantly in both IV and IG TPN groups versus the chow or complex enteral diet group
67  were randomized to receive chow, IV TPN, IG TPN, or an isocaloric, complex enteral diet.
68 y with IV TPN and partial impairment with IG TPN and provide a cytokine-mediated explanation for redu
69                            Intragastric (IG) TPN maintains antiviral defenses but only partially pres
70                                           In TPN group, average energy intake was significantly highe
71 4 h were significantly higher (P < 0.001) in TPN recipients (5.0 +/- 0.9 pmol/L) than in healthy volu
72 eflects titration of histidine residue 12 in TPN(Q) by extracellular protons, since it largely vanish
73                     Methionine residue 13 in TPN interacts with residue F148 in the channel, located
74 (+25%) and intestinal blood volume (+51%) in TPN-fed piglets.
75 EEN group versus 64.4% (95% CI 54.2-73.6) in TPN group (P = 0.040).
76 er parathyroid gland function is abnormal in TPN recipients.
77 e, ERp57 failed to associate with H chain in TPN-deficient.220 cells.
78 ic channels indicate that the differences in TPN sensitivity between rat and human Kir1.1 channels ar
79 lfated monosaccharides were also enriched in TPN samples.
80  due to oxidation of M13, we replaced M13 in TPN with fourteen different residues.
81 ression and phosphorylation were measured in TPN-fed pigs acutely (4 h) infused with GLP-2.
82 thesis that the lack of enteral nutrients in TPN might select commensal or pathogenic bacteria that u
83 matory state and mucosal atrophy observed in TPN-treated mice.
84                 To overcome the reduction in TPN affinity due to oxidation of M13, we replaced M13 in
85 e, enhances the regularity of PTH release in TPN recipients.
86                    The methionine residue in TPN can be oxidized by air, which significantly hinders
87 ed that TNF-alpha plays an important role in TPN-associated EBF dysfunction.
88                   The interaction surface in TPN(Q) is primarily formed by its alpha helix rather tha
89 associated bacteria (100 colonies tested) in TPN compared with 33% of mucus-associated bacteria (100
90                          We conclude that in TPN-fed neonatal pigs, GLP-2 acutely stimulates intestin
91 ation of intestinal substrate utilization in TPN-fed piglets.
92 e significantly greater with GLP-2 infusion (TPN alone: 25 +/- 9 pmol/L; SEN: 29 +/- 10 pmol/L; GLP-2
93 uorescein (CT-FITC) or Diamidino Yellow into TPNs revealed that RPM and TPN motoneurons are indeed in
94                                 Intragastric TPN partially preserved this respiratory immunity.
95 of gut ischemia, the IV-TPN and intragastric TPN groups showed a higher death rate than the chow and
96 en the complex enteral diet and intragastric TPN groups.
97 tes) eliminated any benefits of intragastric TPN on survival.
98  produce GALT atrophy, but only intragastric TPN preserves established antiviral immunity.
99 eral diet group (n = 5) and the intragastric TPN group (n = 5) after 30 minutes of gut ischemia and 1
100 ere randomized to chow, IV-TPN, intragastric TPN, or complex enteral diet for 5 days' feeding.
101                                  Intravenous TPN caused greater bacterial translocation in all small
102 epleting diets (intragastric and intravenous TPN) would impair immunity against bacterial pneumonia.
103 elemental diet) 307 kcal/kg/day, intravenous TPN (parenteral diet) 307 kcal/kg/day via jugular venous
104 nd was lost in animals receiving intravenous TPN.
105     This protection is lost with intravenous TPN, partially preserved with a chemically defined enter
106                 TPN-Y1/K12/Q13 and mono-iodo-TPN-Y1/K12/Q13 ([(127)I]TPN-Y1/K12/Q13) inhibit with hig
107 e association of ERp57 with mouse class I is TPN dependent and parallels that of CRT and not calnexin
108 ps significantly in mice receiving IG and IV TPN in association with reduced IgA levels, whereas IL-1
109 mpairments in mucosal immunity induced by IV TPN.
110 one mice were randomized to receive chow, IV TPN, IG TPN, or an isocaloric, complex enteral diet.
111 t groups, whereas IL-10 decreased only in IV TPN mice.
112                           After 5 days of IV TPN, mice received 0, 1, 2, or 3 days of BBS IV three ti
113 ases significantly only in mice receiving IV TPN.
114 h severely impaired mucosal immunity with IV TPN and partial impairment with IG TPN and provide a cyt
115  were randomized to chow or intravenous (IV) TPN.
116                          In experiment 2, IV-TPN significantly increased pulmonary and hepatic 125I a
117             Mice were randomized to chow, IV-TPN, intragastric TPN, or complex enteral diet for 5 day
118 d for PMNs, the authors hypothesized that IV-TPN may affect organ injury after gut ischemia-reperfusi
119     After 30 minutes of gut ischemia, the IV-TPN and intragastric TPN groups showed a higher death ra
120 ntly reduced the death rate compared with IV-TPN after 15 minutes of I/R.
121        This derivative-denoted tertiapin-KQ (TPN(KQ))-not only is practically insensitive to extracel
122  signaling plays a central role in mediating TPN-induced mucosal atrophy without intact epidermal gro
123                                Using a mouse TPN model, removing enteral nutrition leads to decreased
124                                Using a mouse TPN model, we explored the relative roles of TNFR1 vs. T
125 s were significantly abrogated in MyD88(-/-) TPN mice.
126 th a Ki value very similar to that of native TPN.
127                       However, unlike native TPN, TPN(Q) is nonoxidizable by air.
128  and the nodes of the task positive network (TPN).
129 del entitled Toxicologic Prediction Network (TPN) to assess chronic hepatotoxicity based on subchroni
130 de network (DMN) and task-positive networks (TPNs), would co-occur with structural abnormalities in c
131 connections with two task positive networks (TPNs): frontoparietal network and ventral attention netw
132 y three classes of taste projection neurons (TPNs) in Drosophila melanogaster distinguished by their
133 st 50% of nutritional needs on PoD 5, and no TPN for more than consecutive 48 hours.
134 utrition (Control) or intravenous nutrition (TPN).
135  total or supplemental parenteral nutrition (TPN or PN, respectively).
136  deprivation via total parenteral nutrition (TPN) administration leads to local mucosal inflammatory
137 tients beginning total parenteral nutrition (TPN) and whether a 3-d regimen of TPN would further incr
138 equire long-term total parenteral nutrition (TPN) for intestinal failure and 15% to 40% of adults on
139                  Total parenteral nutrition (TPN) is an invasive and advanced rescue feeding techniqu
140                  Total parenteral nutrition (TPN) is commonly used clinically to sustain patients; ho
141                  Total parenteral nutrition (TPN) leads a loss of epithelial barrier function, declin
142 t deprivation or total parenteral nutrition (TPN) led to a loss of intestinal epithelial barrier func
143 and intragastric total parenteral nutrition (TPN) produce GALT atrophy, but only intragastric TPN pre
144 emically defined total parenteral nutrition (TPN) to genetically normal, immune ICR mice by the i.v.
145 are dependent on total parenteral nutrition (TPN) to prevent hypoglycemia and provide a sufficient en
146 rms of survival, total parenteral nutrition (TPN) weaning, and complications.
147  ventilation and total parenteral nutrition (TPN) were measured for > or = 15 min by using indirect c
148 atients received total parenteral nutrition (TPN) with caloric intake 20% to 30% above their resting
149 ory of long-term total parenteral nutrition (TPN) with TPN-related cholestatic liver disease.
150 ion (NJEEN) with total parenteral nutrition (TPN), after pancreaticoduodenectomy (PD), in terms of po
151 ial reference to total parenteral nutrition (TPN), an area in which I have been involved from 1937 un
152 fection, days of total parenteral nutrition (TPN), and days of injectable narcotic therapy (all over
153  factors such as total parenteral nutrition (TPN), blood product transfusions, invasive procedures, c
154 uding rats given total parenteral nutrition (TPN), IGF-I more potently stimulates mucosal growth than
155 lized a model of total parenteral nutrition (TPN), or enteral nutrient deprivation, to study this int
156  deprivation, or total parenteral nutrition (TPN), resulting in intestinal mucosal atrophy and decrea
157 ce that received total parenteral nutrition (TPN), which deprives the animals of enteral nutrients, d
158 l with long-term total parenteral nutrition (TPN), while others develop life-threatening complication
159                  Total parenteral nutrition (TPN), with the complete removal of enteral nutrition, re
160 LD but developed total parenteral nutrition (TPN)-induced liver failure.
161 eficiency (one), Total Parenteral Nutrition (TPN)-related (one), cryptogenic cirrhosis (one), and hep
162 ith the need for total parenteral nutrition (TPN).
163 by the method of total parenteral nutrition (TPN).
164 complications of total parenteral nutrition (TPN).
165 tients receiving total parenteral nutrition (TPN).
166 r 7 days by oral total parenteral nutrition (TPN; elemental diet) 307 kcal/kg/day, intravenous TPN (p
167 ression would attenuate many of the observed TPN-associated IEL changes.
168 enteral nutrition with the administration of TPN is associated with a loss of intestinal epithelial b
169                            Administration of TPN upregulated the downstream nuclear factor-B and myos
170 enteral nutrition, reverses complications of TPN and avoids intestinal transplantation in the majorit
171 ients with life-threatening complications of TPN.
172 Leptin concentrations increased after 3 d of TPN, from 356 +/- 300 to 794 +/- 600 pmol/L (P < 0.05) i
173 20 (11 women and 9 men) completed all 3 d of TPN.
174 fection (P <.01), (3) 2.7 additional days of TPN (P <.0001), (4) 2.6 additional days of injectable na
175 support and nitrogen balance after 5 days of TPN.
176 Not surprisingly, this alanine derivative of TPN(Q) binds to the channel with much lower affinity.
177 repeat lengthening led to discontinuation of TPN in almost half of these carefully selected patients
178 n mechanistic insights into the functions of TPN.
179  unify our understanding of the functions of TPN.
180  an average of 1.5 y after the initiation of TPN.
181  IEL cytokine expression in a mouse model of TPN.
182 es with class I molecules in the presence of TPN.
183 rect calorimetry and 1.5 g/kg/day protein of TPN.
184                                 Provision of TPN to a goal of 25 kcal/kg was not associated with more
185 nutrition (TPN) and whether a 3-d regimen of TPN would further increase plasma leptin concentrations
186     These findings reveal a critical role of TPN for ER retention of empty class I molecules.
187              To evaluate the in vivo role of TPN, we have generated Tpn mutant mice.
188 g cells in the nasal passages and spleens of TPN-fed mice was unaffected, while both the number and t
189                             The stability of TPN(Q) allows us to investigate how it interacts with th
190           Survival after the clinical use of TPN >6 mo is unknown.
191 58% in 437 patients with a first-time use of TPN at an average of 1.5 y after the initiation of TPN.
192  the region underlies the great variation of TPN affinities among eukaryotic Kir channels.
193                                Activation of TPNs influences innate feeding behavior, whereas inhibit
194       Sixty-nine percent of patients are off TPN at most recent follow-up, including 8 who were weane
195 nctioning and the patient was completely off TPN.
196 y equal to or better than quality of life on TPN and children report quality of life similar to norma
197 icantly higher in IFN-gamma knockout mice on TPN compared to C57BL/6 mice that received TPN.
198  via GLM could be a strategy for patients on TPN.
199                                      Rats on TPN received vehicle, GH, or IGF-I.
200 channel is a bimolecular reaction, i.e., one TPN(Q) molecule binds to one channel.
201 al unit acting as a docking site for optimal TPN/MHC I recruitment, whereas three distinct highly con
202 patients undergoing PD to NJEEN (n = 103) or TPN (n = 101).
203 d by total enteral nutrition (TEN; n = 6) or TPN (n = 5) were compared with the use of 16S ribosomal
204 mice were provided either enteral feeding or TPN.
205 nulation and were given enteral nutrition or TPN for 7 days.
206                                         Oral TPN caused gut barrier failure only in the ileal segment
207 by bilateral muscles: the transversus penis (TPN) and retractor penis magnus (RPM).
208 one of these muscles, the transversus penis (TPN), were localized by using the retrograde tracer bioc
209 strongly suggest that to block the K(+) pore TPN(Q) plugs its alpha helix into the vestibule of the K
210 ve significant clinical potential to prevent TPN-associated atrophy.
211        TLR4 blockade significantly prevented TPN-associated atrophy by preserving proliferation and p
212                  GLM significantly prevented TPN-associated intestinal atrophy (2.5-fold increase in
213                                 Tertiapin-Q (TPN(Q)), a honey bee toxin derivative, inhibits inward-r
214  patients received standard TPN, 10 received TPN plus daily injections of GH, and 10 received daily G
215                           One group received TPN without chow, and controls received standard chow.
216                  Adult C57BL/6 mice received TPN or enteral diet for 7 days.
217 n TPN compared to C57BL/6 mice that received TPN.
218   We conclude that in VLBW infants receiving TPN, normoglycemia was maintained during reduced glucose
219 F-alpha blockade in wild-type mice receiving TPN confirmed that soluble TNF-alpha signaling is respon
220 phy in TLR4 knockout (TLR4KO) mice receiving TPN.
221         In critically ill patients receiving TPN, indirect calorimetry, if available, remains the mos
222                  Experimental rats receiving TPN were able to process infused glucose completely at r
223                Twenty-six patients requiring TPN were enrolled in this prospective, nonintervention s
224 ere the following: transection or resection (TPN alone), +/- SEN (days 4-6), and +/- GLP-2 (100 mug .
225  N-domain binds to the TM region of a single TPN molecule, which recruits one MHC I molecule to TAP1
226 after surgery: 10 patients received standard TPN, 10 received TPN plus daily injections of GH, and 10
227 lay an important role in development of such TPN-associated IEL changes.
228                          We propose that TAP/TPN complex formation is driven by hydrophobic interacti
229 esulting in greater significance of the TAP2/TPN interaction for MHC loading.
230 ultifactorial complex that includes tapasin (TPN), a membrane protein that tethers empty class I glyc
231  examined interactions in a soluble tapasin (TPN)/HLA-B*0801 complex to gain mechanistic insights int
232 ide-loading complex (PLC), to which tapasin (TPN) recruits MHC class I (MHC I) and accessory chaperon
233 roid gland function is abnormal in long-term TPN recipients, which may contribute to disturbances in
234                                   Tertiapin (TPN), a small protein toxin originally isolated from hon
235                  In this respect, tertiapin (TPN), a 21 amino acid peptide isolated from bee venom, h
236 o the channel with even higher affinity than TPN(Q) at extracellular pH 7.6.
237           In the present study we found that TPN(Q) inhibition of the channels is profoundly affected
238                            Results show that TPN acts as a chaperone by increasing the ratio of activ
239                            We also show that TPN sensitivity can be readily conferred onto some Kir c
240                        Our study showed that TPN administration led to significant changes in IEL phe
241                     Previous work shows that TPN results in a loss of intestinal epithelial cell-deri
242                              We suggest that TPN influences presentation of antigenic peptides accord
243                                          The TPN-associated downregulation of junctional protein expr
244 uption in the segregation of the DMN and the TPN at rest may be mediated through both a direct pathwa
245 ncreased functional connectivity between the TPN and SN appears to be associated with reduced perform
246 nectivity was also observed between both the TPN and DMN and nodes associated with the Salience Netwo
247                   Control rats consuming the TPN solution by mouth ingested glucose at 42 mmol/day an
248 mTBI patients with memory complaints for the TPN.
249 oup to 0.44 +/- 0.11 attomoles/microL in the TPN group (P <.05).
250 c pathogen, was specifically enriched in the TPN ileum (P < 0.05).
251                Baseline plasma leptin in the TPN patients ranged from 62.5 to 1625 pmol/L ( +/- SD: 4
252 concentrations were moderately higher in the TPN recipients than in healthy volunteers, and values ob
253 itrate-induced hypocalcemia was lower in the TPN recipients, consistent with secondary hyperparathyro
254 d through an indirect pathway that links the TPN and DMN through nodes of the SN.
255 unted for 96% of the T17-S1 motoneurons: the TPN, RPM, caudifemoralis (CF), and cloacal sphincter (SC
256 of increased FC between various nodes of the TPN and DMN, and through an indirect pathway that links
257                        The advantages of the TPN are further demonstrated through two novel applicati
258 d gain a more accurate representation of the TPN motoneuron pool.
259 onation of the histidine residue reduces the TPN(Q)-ROMK1 binding energy by 1.6 kcal/mol.
260                    In the present study, the TPN derivative, TPN-Y1/K12/Q13, has been synthesized and
261                Motoneurons projecting to the TPN lie in spinal segments trunk 17 and sacral 1 (T17-S1
262 ritional factors, glutamine was added to the TPN solution.
263  the GH and insulin groups compared with the TPN only group.
264 muscle protein net balance compared with the TPN only group.
265                                          The TPNs essential for conditioned aversion project to the s
266 d could be a contributing mechanism for this TPN-associated loss of EC proliferation.
267 when enteral nutrients were withheld in this TPN piglet model.
268                            BBS prevents this TPN-induced GALT atrophy, depressed gastrointestinal and
269                                        Thus, TPN administration is associated with significant expans
270 ed that EGF signaling is preserved in TLR4KO-TPN mice and prevents mucosal atrophy.
271  Bcl-2 was significantly increased in TLR4KO-TPN mice, while Bax decreased 10-fold.
272 increased, and TNF-alpha decreased in TLR4KO-TPN versus wild-type (WT)-TPN mice.
273  were 15-fold higher in WT-TPN versus TLR4KO-TPN mice.
274 lpha blockade, but not in TNFR1KO or TNFR2KO TPN groups.
275 ed whether some supplement could be added to TPN to avoid this GALT atrophy and lower the incidence o
276 ific contributions of TNF-alpha signaling to TPN-induced mucosal atrophy remain unclear.
277 (+) channels with affinities very similar to TPN.
278                  However, unlike native TPN, TPN(Q) is nonoxidizable by air.
279                                Moreover, two TPN classes are absolutely required for conditioned tast
280 n decreased 1.7-fold compared with wild-type TPN mice.
281 junctional protein losses in mice undergoing TPN.
282                                        Using TPN-treated IEC-specific ADAM17-deficient mice, the pres
283 ne (LDD) for renal protection, vasopressors, TPN, and enteral feeding.
284 fe-threatening complications or fail to wean TPN.
285  These findings suggest a mechanism by which TPN results in observed IEL changes.
286 ss of the epithelial barrier associated with TPN.
287  findings of mucosal atrophy associated with TPN.
288 microbiota (but distinct from controls) with TPN.
289 egulatory cells significantly decreased with TPN in WT mice.
290                GLM led to a loss of EBF with TPN (60% increase in FITC-dextran permeability, 40% decl
291 atory cytokines significantly increased with TPN.
292 hanges were observed in MyD88(-/-) mice with TPN administration.
293               Loss of luminal nutrients with TPN administration may widely affect intestinal taste se
294  findings, the loss of EC proliferation with TPN may well be due to a loss of total beta-catenin, as
295 The marked decline in IEC proliferation with TPN was nearly prevented in TLR4KO mice, and intestinal
296 tokine expression changes significantly with TPN administration.
297 barrier function declined significantly with TPN compared to controls.
298 g-term total parenteral nutrition (TPN) with TPN-related cholestatic liver disease.
299 robiota were Firmicutes-dominant, whereas WT TPN mice were Proteobacteria-domiant.
300 ecreased in TLR4KO-TPN versus wild-type (WT)-TPN mice.
301 sitive crypt cells were 15-fold higher in WT-TPN versus TLR4KO-TPN mice.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top